The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ARVINAS INC | COM | 04335A105 | 10,095 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
CEREVEL THERAPEUTICS HLDNG I | COM | 15678U128 | 5,952 | 170,000 | SH | SOLE | 170,000 | 0 | 0 | ||
COGENT BIOSCIENCES INC | COM | 19240Q201 | 9,808 | 1,309,430 | SH | SOLE | 1,309,430 | 0 | 0 | ||
FATE THERAPEUTICS INC | COM | 31189P102 | 7,037 | 181,500 | SH | SOLE | 181,500 | 0 | 0 | ||
GUARDANT HEALTH INC | COM | 40131M109 | 10,598 | 160,000 | SH | SOLE | 160,000 | 0 | 0 | ||
GOSSAMER BIO INC | COM | 38341P102 | 3,906 | 450,000 | SH | SOLE | 450,000 | 0 | 0 | ||
IVERIC BIO INC | COM | 46583P102 | 10,940 | 650,000 | SH | SOLE | 650,000 | 0 | 0 | ||
ISOPLEXIS CORP | COM | 465005106 | 5,660 | 1,650,118 | SH | SOLE | 1,650,118 | 0 | 0 | ||
JOUNCE THERAPEUTICS INC | COM | 481116101 | 3,735 | 550,000 | SH | SOLE | 550,000 | 0 | 0 | ||
LANTHEUS HLDGS INC | COM | 516544103 | 15,763 | 285,000 | SH | SOLE | 285,000 | 0 | 0 | ||
MEDAVAIL HOLDINGS INC | COM | 58406B103 | 2,836 | 2,920,780 | SH | SOLE | 2,920,780 | 0 | 0 | ||
NAUTILUS BIOTECHNOLOGY INC | COM | 63909J108 | 4,690 | 1,080,566 | SH | SOLE | 1,080,566 | 0 | 0 | ||
INTELLIA THERAPEUTICS INC | COM | 45826J105 | 4,360 | 60,000 | SH | SOLE | 60,000 | 0 | 0 | ||
NUVATION BIO INC | COM CL A | 67080N101 | 5,981 | 1,137,152 | SH | SOLE | 1,137,152 | 0 | 0 | ||
RAPID MICRO BIOSYSTEMS INC | CLASS A COM | 75340L104 | 4,751 | 699,664 | SH | SOLE | 699,664 | 0 | 0 | ||
SIGHT SCIENCES INC | COM | 82657M105 | 3,639 | 314,804 | SH | SOLE | 314,804 | 0 | 0 | ||
SOMALOGIC INC | CLASS A COM | 83444K105 | 5,895 | 735,000 | SH | SOLE | 735,000 | 0 | 0 | ||
STOKE THERAPEUTICS INC | COM | 86150R107 | 3,684 | 175,000 | SH | SOLE | 175,000 | 0 | 0 | ||
SYROS PHARMACEUTICALS INC | COM | 87184Q107 | 4,004 | 3,364,895 | SH | SOLE | 3,364,895 | 0 | 0 | ||
VERVE THERAPEUTICS INC | COM | 92539P101 | 2,404 | 105,360 | SH | SOLE | 105,360 | 0 | 0 | ||
VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 9,171 | 496,012 | SH | SOLE | 496,012 | 0 | 0 |